SEC Form 4 · accession 0001144204-18-033532
ANI PHARMACEUTICALS INC · ANIP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Patrick D Walsh
Director
Period of report
Jun 6, 2018
Accepted (ET)
Jun 8, 2018 · 4:02 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001023024
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jun 6, 2018 | A | 1,800 | $0.00 | A | 1,800 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionsF1 | $65.86 | Jun 6, 2018 | A | 2,225 | A | — | Jun 5, 2028 | Common Stock | 2,225 | 2,225 | D |
Explanation of responses
- F1The restricted stock and stock options are subject to vesting, and 50% of the restricted stock and stock options vest on May 17, 2019, and the remaining 50% of the restricted stock and stock options vest on May 17, 2020.